Arcturus Therapeutics Holdings Inc’s recently made public that its Chief Scientific Officer & COO Chivukula Pad unloaded Company’s shares for reported $0.25 million on Oct 15 ’24. In the deal valued at $20.76 per share,12,000 shares were sold. As a result of this transaction, Chivukula Pad now holds 435,334 shares worth roughly $7.36 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Chivukula Pad bought 12,000 shares, generating $249,121 in total proceeds.
Before that, SASSINE ANDY sold 50,000 shares. Arcturus Therapeutics Holdings Inc shares valued at $1,601,500 were divested by the Chief Financial Officer at a price of $32.03 per share. As a result of the transaction, SASSINE ANDY now holds 220,526 shares, worth roughly $3.73 million.
Leerink Partners initiated its Arcturus Therapeutics Holdings Inc [ARCT] rating to an Outperform in a research note published on August 12, 2024; the price target was $70. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. William Blair began covering ARCT with “an Outperform” recommendation on July 24, 2023. H.C. Wainwright revised its rating on May 11, 2023. It rated ARCT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ARCT
On Friday, Arcturus Therapeutics Holdings Inc [NASDAQ:ARCT] saw its stock fall -0.94% to $16.91. Over the last five days, the stock has gained 5.56%. Arcturus Therapeutics Holdings Inc shares have fallen nearly -46.37% since the year began. Nevertheless, the stocks have fallen -28.13% over the past one year. While a 52-week high of $45.00 was reached on 06/05/24, a 52-week low of $14.93 was recorded on 11/15/24. SMA at 50 days reached $20.22, while 200 days put it at $26.57.
Levels Of Support And Resistance For ARCT Stock
The 24-hour chart illustrates a support level at 16.24, which if violated will result in even more drops to 15.57. On the upside, there is a resistance level at 17.54. A further resistance level may holdings at 18.17. The Relative Strength Index (RSI) on the 14-day chart is 41.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.36%. Stochastics %K at 26.75% indicates the stock is a holding.
How much short interest is there in Arcturus Therapeutics Holdings Inc?
A steep rise in short interest was recorded in Arcturus Therapeutics Holdings Inc stocks on 2024-10-31, dropping by 16024.0 shares to a total of 4.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 4.6 million shares. There was a decline of -0.35%, which implies that there is a negative sentiment for the stock.
